Drug Research
Araris Biotech AG Announces Strategic Investment with Samsung Ventures
Araris Biotech AG, a company pioneering a proprietary antibody-drug conjugate (ADC)-linker technology,announced that Samsung Venture Investment Corporation (“Samsung Ventures”), an investment corporation established to promote the development of new technologies, has invested in the Company in an independent deal...
Drug Research
CBM Completes Tech Transfer for Manufacturing Platform for AAV Production
The Center for Breakthrough Medicines (CBM), a contract development and manufacturing organization (CDMO) dedicated to addressing critical challenges associated with the commercialization of cell and gene therapies, has completed a successful technology transfer of the University of Pennsylvania Gene...
News
UNDBIO to Build $100M Insulin Manufacturing Facility in West Virginia
UNDBIO, a South Korean pharmaceutical company focused on diabetic care, will spend $100 million to build an insulin manufacturing facility in West Virginia.
The project is expected to create 200 new jobs in the first three years, according to an April...
Drug Research
Singapore Scouts New Targeted Cancer Treatment Therapies
Cancer happens to be a leading cause of global death and accounts for almost one in six fatalities, with metastatic cancers contributing more than 90% of the overall cancer-related deaths. Apparently, metastatic cancers take place when the cancer cells...
Drug Research
Malaria Jab From Oxford University Gets Ghana FDA Thumbs Up
A malaria vaccine called R21/Matrix-M, which was developed in collaboration with the University of Oxford as well as a manufacturer of vaccines and immunological products from India, has been given the licence to be used in Ghana by the...
Drug Research
Potential Target Identified To Combat Blood Cancer – Study
A worldwide consortium that comprises biomedical researchers co-led by Alexander Bick, MD, PhD, at the Vanderbilt University Medical Centre, has come up with a new way to gauge the precancerous clones of blood stem cells that would go on...
Drug Research
Bora Pharmaceuticals and Celltrion partner to expand OSD capabilities in the APAC market
Bora Pharmaceuticals Co., Ltd. and Celltrion Asia Pacific Pte., Ltd. , a subsidiary of Celltrion Group Inc, have announced their partnership to contract manufacture and commercialize a range of oral dosage form drugs (OSD) across the APAC region.
The range...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read